Clinical Trial Update: Safety and Tolerability Study of Larazotide Acetate in Celiac Disease Subjects [Phase 2]

View source ↗

Summary

Phase 2 safety and tolerability study of larazotide acetate in subjects with celiac disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Celiac Disease

Drugs mentioned

• larazotide acetate (larazotide acetate)

Snippet

Sponsor: 9 Meters Biopharma, Inc. | Conditions: Celiac Disease | Phase 2 | Status: COMPLETED